Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth
Benchmark: BSE Healthcare TRI · Riskometer: Very High
₹41.23
NAV (2026-08-31)
₹1,102.73 Cr
AUM (2026-08-31)
1.02%
EXPENSE RATIO (DIRECT)
2019-06-20
INCEPTION
Punji Fund Health Score - percentile-within-category. See methodology.
CHART
Rolling CAGR by holding period - min, median, max
Each group is one holding-period length. Full range of outcomes across every overlapping window in the fund's history, not one trailing number.
| Metric | Value | Percentile | Category median |
|---|---|---|---|
| 3Y Rolling CAGR | 19.7% | 71.84th | 17.5% |
| 3Y Sharpe Ratio | 1.21 | 96.4th | 0.63 |
| 3Y Alpha | 2.1% | 45.45th | 2.7% |
| 3Y Std Deviation | 13.4% | 81.08th (lower is better) | 15.0% |
1.213
1.8779
2.1207
0.8481
13.4244
-15.9314
88.6516
82.7144
4.8068
Tracking Error (%)
1.4546
3-year window vs. BSE Healthcare TRI.
CHART
Top sector holdings
Share of portfolio (% to NAV) in each of the top sectors.
TOP HOLDINGS
Funds that behave most similarly (beta, capture ratios, volatility - not holdings overlap). Pick up to 2 to compare alongside this fund:
CHART
Asset Allocation
As of Jul-2026
CHART
Market Cap Split
As of Jul-2026
Portfolio analytics as of Jul-2026.
Data as of 2026-09-02. Source: AMFI disclosures via Punji. Not investment advice.